[1]CHEN S C, TSENG C H. Dyslipidemia, kidney disease, and cardiovascular disease in diabetic patients[J]. Rev Diabet Stud, 2013, 10(23):88100.
[2]TSENG C H. Differential dyslipidemia associated with albuminuria in type 2 diabetic patients in Taiwan[J]. Clin Biochem, 2009, 42(1011):10191024.
[3]LING Y, LI X, GU Q, et al. Circulating ApoE level is independently associated with urinary albumin excretion in type 2 diabetic patients[J]. Intern Med, 2011, 50(24):29612966.
[4]PAN J, GAO F, BAO Y, et al. Nonhighdensity lipoprotein cholesterol is associated more closely with albuminuria in Chinese type 2 diabetic patients with normal renal function, compared with traditional lipid parameters[J]. J Clin Lipidol, 2012, 6(4):382387.
[5]LEVEY A S, BOSCH J P, LEWIS J B, et al. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of diet in Renal Disease Study Group[J]. Ann Intern Med, 1999, 130: 461470.
[6]TSIMIHODIMOS V, DOUNOUSI E, SIAMOPOULOS K C.Dyslipidemia in chronic kidney disease: an approach to pathogenesis and treatment[J]. Am J Nephrol, 2008, 28(6):958973.
[7]LU W, RESNICK H E, JABLONSKI K A, et al. NonHDL cholesterol as a predictor of cardiovascular disease in type 2 diabetes: The strong heart study[J]. Diabetes Care, 2003, 26(1):1623.
[8]MIREMADI S, SNIDERMAN A, FROHLICH J. Can measurement of serum apolipoprotein B replace the lipid profile monitoring of patients with lipoprotein disorders[J]. Clin Chem, 2002, 48:484488.
[9]TSENG C H. Lipoprotein(a) is an independent risk factor for peripheral arterial disease in Chinese type 2 diabetic patients in Taiwan[J]. Diabetes Care, 2004, 27:517521.
[10]CINZIA F, DANIELA P, ELENA S, et al. Lipoprotein (a) [Lp(a)]: a possible link between migraine and stroke[J]. Transl Res, 2009, 153:4447.
[11]GALLE J, SCHNEIDER R, HEINLOTH A, et al. Lp(a) and LDL induce apoptosis in human endothelial cells and in rabbit aorta: role of oxidative stress[J]. Kidney Int, 1999, 55:14501461.
[12]CHEN S C, HUNG C C, KUO M C, et al. Association of dyslipidemia with renal outcomes in chronic kidney disease[J]. PLoS One, 2013, 8(2):e55643.
[13]HOLZMANN M J, JUNGNER I, WALLDIUS G, et al. Dyslipidemia is a strong predictor of myocardial infarction in subjects with chronic kidney disease[J]. Ann Med, 2012, 44(3):262270
[14]COLHOUN H M, BETTERIDGE D J, DURRINGTON P N, et al. Effects of atorvastatin on kidney outcomes and cardiovascular disease in patients with diabetes: an analysis from the Collaborative Atorvastatin Diabetes Study (CARDS)[J]. Am J Kidney Dis, 2009, 54(5):810819.
[15]CHEN S C, HUNG C C, TSAI Y C, et al. Association of cholesterol levels with mortality and cardiovascular events among patients with CKD and different amounts of proteinuria[J]. Clin J Am Soc Nephrol, 2013, 8(11):19151926.
[16]SONG K H, KO S H, KIM H W, et al. Prospective study of lipoprotein(a) as a risk factor for deteriorating renal function in type 2 diabetic patients with overt proteinuria[J]. Diabetes Care, 2005, 28(7):17181723. |